Equity · Healthcare
MGX
NASDAQMetagenomi (MGX)
The line runs 1.22 USD on 24 August through 0.6303 USD on 17 November, on a scale from 0.6 to 1.4. Days the market did not trade hold the previous close, flat.
- Market cap
- 23.8M USD
- Revenue, year to Dec 2025
- 25.2M USD
- EPS, diluted, year to Dec 2025
- −2.36 USD
- 52-week range
- 0.6303 USD – 2.15 USD
- Avg volume
- 4.8K
as of Nov 17, 2026
Have Metagenomi (MGX) insiders bought or sold shares recently?
In the 90 days to 21 Nov 2026, Metagenomi insiders reported 3 open-market sales and 1 purchase (SEC Form 4).
Form 4, 90 days to 21 Nov 2026, newest reported trade 9 Sep 2026
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 09 Sep 2026 | Reid LaurenceDirector | Buy | 20,000 | 23K USD |
| 08 Sep 2026 | Wein MatthewSee Remarks | Sell | 358 | 415 USD |
| 08 Sep 2026 | Irish JianSee Remarks | Sell | 2,140 | 2K USD |
| 08 Sep 2026 | Wapnick PamelaChief Financial Officer | Sell | 1,911 | 2K USD |
| Bought | 1 open-market purchase | 20,000 | $23K | |
| Sold | 3 open-market sales | 4,409 | $5K |
Which funds hold Metagenomi (MGX)?
5 of the 45 institutional funds we track reported a Metagenomi position for the quarter ended 30 Sep 2026 — a combined 1.5M USD; the latest of those filings landed 16 Nov 2026.
| Fund | Position | Shares | Value | Shares q/q |
|---|---|---|---|---|
| Renaissance Technologies | Held (±25%) | 624,300 | 662K USD | −15.9% |
| Two Sigma Investments | Held (±25%) | 504,515 | 535K USD | −1.8% |
| Man Group | Added | 141,896 | 150K USD | +30.0% |
| Millennium Management | Trimmed | 75,402 | 80K USD | −33.9% |
| Citadel Advisors | Added | 49,266 | 52K USD | +176.0% |
What has been filed or recorded for Metagenomi (MGX)?
The filings we hold for Metagenomi, newest first: 2 fails-to-deliver days, 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 28 Oct 2026. No next earnings date is announced in SEC filings yet.
| And | ||||
|---|---|---|---|---|
| 28 Oct 2026 | Fails to deliver | Shares failed to deliver | 8,531 shares | 7K USD notional · 0.023% of shares out |
| 13 Oct 2026 | Fails to deliver | Shares failed to deliver | 1,997 shares | 2K USD notional · 0.005% of shares out |
| 30 Sep 2026 | Quarterly earnings | Q3 2026 reported | EPS −0.56 USD | Revenue $2M |
| 30 Sep 2026 | Financials | Total assets | 157.4M USD | at period end |
| 30 Sep 2026 | Financials | Total equity | 93.2M USD | at period end |
| 30 Jun 2026 | Quarterly earnings | Q2 2026 reported | EPS −0.73 USD | |
| 31 Mar 2026 | Quarterly earnings | Q1 2026 reported | EPS −0.61 USD | Revenue $1M |
| 31 Dec 2025 | Annual report | FY 2025 reported | EPS −2.36 USD | Revenue $25M |
| 31 Dec 2025 | Financials | Revenue | 25.2M USD | fiscal year |
| 31 Dec 2025 | Financials | Net income | −87.9M USD | fiscal year |
| 31 Dec 2025 | Financials | Diluted EPS | −2.36 USD | fiscal year |
| 30 Sep 2025 | Quarterly earnings | Q3 2025 reported | EPS −0.55 USD | Revenue $9M |
| 30 Jun 2025 | Quarterly earnings | Q2 2025 reported | EPS −0.54 USD | Revenue $9M |
| 31 Mar 2025 | Quarterly earnings | Q1 2025 reported | EPS −0.68 USD | Revenue $4M |
| 31 Dec 2024 | Annual report | FY 2024 reported | EPS −2.36 USD | Revenue $52M |
What do people ask about Metagenomi (MGX)?
What did Metagenomi shares close at?0.6303
Metagenomi closed at 0.6303 USD on 17 Nov 2026, down 6.15% on the close before. That is the end-of-day price from Finazon, not a live quote.
What is Metagenomi’s market cap?23.8M
Metagenomi is worth 23.8M USD by market value as of 17 Nov 2026, which is the share price times the shares on issue from its SEC filings.
What is Metagenomi’s revenue?25.2M
Metagenomi reported revenue of 25.2M USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings
Have Metagenomi insiders bought or sold shares recently?3 sales
In the 90 days to 21 Nov 2026, Metagenomi insiders reported 3 open-market sales and 1 purchase (SEC Form 4). See Insiders
Which funds own Metagenomi?5 of 45
5 of the 45 funds we track reported a Metagenomi position for the quarter ended 30 Sep 2026, per their SEC Form 13F filings. The largest reported positions were Renaissance Technologies, Two Sigma Investments and Man Group. See Funds
When did Metagenomi last report earnings?−0.56
Metagenomi last reported earnings on 30 Sep 2026 for Q3 2026, with EPS of −0.56 USD; no next date is announced in SEC filings yet. See Filings

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.
References
- Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
- TradingViewthe price chart widget, drawn by TradingView from their own data
- SEC EDGARForm 4 filings (insider transactions)
- SEC EDGAR13F filings
- SECSEC fails-to-deliver (CNS) data
- SEC EDGARXBRL company facts, latest period ended 30 Sep 2026
- SEC EDGARreported earnings figures and scheduled report dates
- SEC EDGARValuation computed from SEC EDGAR filings
- SEC filingAbout text: the company's latest annual report filed with the SEC (Business section), summarised in our own words